Ansell Limited (ANSLY) Stock Analysis

Ansell Limited (ANSLY) Healthcare & Pipeline Overview

Ansell Limited, founded in 1893 and headquartered in Richmond, Australia, is a global leader in protection solutions, specializing in the design, development, and manufacture of surgical, examination, and industrial gloves, alongside chemical protective clothing. Operating across Healthcare and Industrial segments, the company serves diverse markets from hospitals to heavy industries globally.

What Is the Investment Thesis for ANSLY?

With a market capitalization of $3.79B and a P/E ratio of 20.30, the company demonstrates profitability with a 6.7% profit margin and a robust 41.9% gross margin. The dividend yield of 2.75% offers income potential, while a Beta of 0.55 indicates lower volatility compared to the broader market. Key growth catalysts include the consistent global demand for healthcare-related PPE driven by an aging population and increased surgical procedures, coupled with stringent industrial safety regulations across various sectors. The company's extensive global distribution network and strong brand recognition provide a competitive advantage. However, as an ADR trading on the OTC Other tier, investors may want to evaluate potential risks associated with lower liquidity and varying reporting standards. Monitoring global economic conditions and raw material costs is crucial, as these factors can significantly impact Ansell's profitability and operational efficiency.

Based on FMP financials and quantitative analysis

ANSLY Key Highlights

Market Capitalization of $3.79B reflects a significant presence in the global protection solutions market.

• A P/E ratio of 20.30 indicates the market's valuation of its earnings, positioning it within the broader industry context.
• Profit Margin of 6.7% demonstrates the company's ability to convert revenue into net income efficiently.
• Gross Margin of 41.9% highlights strong profitability at the product level, indicating effective cost management and pricing power.
• A Dividend Yield of 2.75% provides a return to shareholders, underscoring a commitment to shareholder value.

Who Are ANSLY's Competitors?

ANSLY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ANSLY's Key Strengths?

Long-standing global brand reputation and market leadership in protection solutions.

• Diversified revenue streams from two robust segments: Healthcare and Industrial.
• Extensive global presence across Asia Pacific, Europe, Middle East, Africa, Latin America, and North America.
• Strong gross margin of 41.9% indicating efficient production and pricing power.

What Are ANSLY's Weaknesses?

Exposure to fluctuations in raw material costs, which can impact profitability.

• As an ADR on the OTC Other tier, it may face lower liquidity compared to major exchange listings.
• Dependence on global economic conditions affecting industrial output and healthcare spending.
• Potential for increased competition from local manufacturers in diverse global markets.

What Could Drive ANSLY Stock Higher?

Continued global expansion of healthcare infrastructure and services, driving demand for medical PPE.

• Implementation of stricter industrial safety regulations worldwide, increasing the need for specialized protective clothing.
• Successful introduction of innovative products leveraging advanced materials or smart technology, enhancing market share.
• Strategic acquisitions or partnerships that expand product lines or geographic reach, contributing to revenue growth.
• Favorable shifts in raw material costs, leading to improved profit margins and operational efficiency.

What Are the Key Risks for ANSLY?

Fluctuations in raw material costs, particularly for polymers and chemicals, could compress profit margins.

• Intense competition from both established global players and local manufacturers in diverse markets.
• Adverse currency exchange rate movements, especially between AUD and USD, impacting reported financial performance for ADR holders.
• Global economic downturns or recessions could reduce industrial activity and healthcare spending, affecting demand.
• Supply chain disruptions due to geopolitical events, natural disasters, or trade protectionism, impacting production and distribution.

What Are the Growth Opportunities for ANSLY?

• **Expanding Global Healthcare Demand**: The healthcare segment is poised for sustained growth due to an aging global population, increasing prevalence of chronic diseases requiring medical intervention, and a heightened focus on infection control. Ansell's comprehensive range of surgical, examination, and sterile gloves and garments directly addresses these needs. The global medical gloves market, for instance, is projected to continue its expansion, driven by rising healthcare expenditure and increased surgical volumes, providing a substantial and ongoing market for Ansell's core products over the next decade.
• **Stricter Industrial Safety Regulations**: Governments and international bodies are continuously implementing more stringent occupational safety and health regulations across various industrial sectors. This regulatory push mandates the use of high-quality protective clothing and hand protection in industries such as chemical, automotive, and oil & gas. Ansell's specialized industrial segment is well-positioned to benefit from this trend, offering advanced chemical protective clothing and durable gloves that meet evolving safety standards, ensuring consistent demand for its solutions in the long term.
• **Penetration into Emerging Markets**: Significant growth opportunities exist in emerging economies across Asia Pacific, Latin America, and Africa. As these regions experience rapid industrialization, economic development, and improvements in healthcare infrastructure, the demand for reliable protection solutions is expected to surge. Ansell's established global presence allows it to strategically expand its distribution channels and market penetration in these high-growth areas, tapping into new customer bases and increasing its overall market share over the next five to ten years.
• **Product Innovation and Advanced Materials**: Continuous innovation in material science and product design offers a key growth avenue. Developing next-generation protective solutions with enhanced comfort, dexterity, durability, and sustainability features can differentiate Ansell from competitors. Investments in R&D for smart PPE, biodegradable materials, or specialized coatings that offer superior protection against new threats can open up premium market segments and sustain competitive advantage, driving growth over the medium to long term.
• **Strategic Acquisitions and Partnerships**: Inorganic growth through targeted acquisitions or strategic partnerships can significantly expand Ansell's product portfolio, technological capabilities, or geographic reach. Identifying and integrating smaller, innovative companies specializing in niche protection solutions or advanced manufacturing techniques could enhance Ansell's market position and create synergies. This strategy allows for rapid market entry into new segments or regions, contributing to accelerated growth and diversification of revenue streams within the next three to five years.

What Are ANSLY's Competitive Advantages?

• Established global brand reputation built over a century in protection solutions.
• Extensive product portfolio catering to diverse and critical healthcare and industrial needs.
• Global distribution network spanning multiple continents, ensuring broad market reach.
• Strong relationships with institutional buyers in healthcare and large industrial clients.
• Expertise in material science and manufacturing processes for specialized protective equipment.

What Does ANSLY Do?

Ansell Limited, a company with a rich history dating back to its founding in 1893, has evolved into a prominent global designer, developer, and manufacturer of advanced protection solutions. Originally known as Pacific Dunlop Limited, the company rebranded to Ansell Limited in 2002, solidifying its focus on safety and protection. Headquartered in Richmond, Australia, Ansell operates through two primary segments: Healthcare and Industrial, demonstrating a diversified approach to the personal protective equipment (PPE) market. The Healthcare segment is dedicated to producing and marketing a comprehensive range of solutions vital for medical and life sciences professionals. This includes surgical gloves, single-use and examination gloves, and specialized clean and sterile gloves and garments. These products are critical for maintaining aseptic environments and protecting personnel in hospitals, surgical centers, dental practices, veterinary clinics, and laboratories, as well as for first responders and pharmaceutical companies. The Industrial segment focuses on manufacturing and marketing hand and chemical protective clothing solutions tailored for a vast array of industrial applications. Its products are essential for worker safety in demanding sectors such as automotive, chemical processing, metal fabrication, machinery and equipment, food processing, construction, mining, oil and gas, and for first responders. Ansell's extensive geographic footprint spans the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America, underscoring its global market presence. With P. D. Holdings Pty. Ltd. operating as a current subsidiary, Ansell Limited continues to leverage its established brand reputation and extensive product portfolio to address the evolving protection needs of a global clientele.

What Products and Services Does ANSLY Offer?

• Designs and develops protection solutions for various industries and healthcare.
• Manufactures surgical gloves, single-use, and examination gloves for medical use.
• Produces clean and sterile gloves and garments for hospitals and laboratories.
• Creates hand and chemical protective clothing for industrial applications.
• Serves hospitals, surgical centers, dental practices, and veterinary clinics.
• Supplies first responders, laboratories, and life sciences companies.
• Provides solutions for automotive, chemical, metal fabrication, and food industries.
• Offers protective gear for construction, mining, oil and gas sectors.

How Does ANSLY Make Money?

• Designs, manufactures, and markets a diversified portfolio of protection solutions.
• Operates through two primary segments: Healthcare and Industrial, catering to distinct customer needs.
• Generates revenue from direct sales and distribution networks across multiple continents.
• Focuses on providing essential, high-quality personal protective equipment (PPE) for safety and hygiene.
• Leverages a global supply chain and established brand reputation to maintain market presence.

What Industry Does ANSLY Operate In?

Ansell Limited operates within the critical and growing Medical - Instruments & Supplies industry, specifically focusing on personal protective equipment (PPE) for both healthcare and industrial sectors. The global PPE market is characterized by increasing demand driven by heightened health and safety awareness, stricter regulatory frameworks, and ongoing industrialization in emerging economies. Ansell's dual segment structure positions it to capitalize on growth in both the healthcare sector, fueled by demographic shifts and medical advancements, and the industrial sector, propelled by manufacturing expansion and occupational safety mandates. The competitive landscape includes specialized PPE manufacturers and broader medical device companies. Ansell differentiates itself through its long-standing brand reputation, extensive product portfolio, and global distribution network, allowing it to maintain a significant share in a fragmented yet essential market.

Who Are ANSLY's Key Customers?

• Hospitals, surgical centers, dental practices, and veterinary clinics.
• First responders, laboratories, and life sciences companies.
• Pharmaceutical companies requiring clean and sterile environments.
• Industrial sectors including automotive, chemical, and metal fabrication.
• Food processing, construction, mining, and oil & gas industries.

Ansell Limited (ANSLY) Valuation Context

Valued at $3.79B, ANSLY is classified as a mid-cap stock.

ANSLY Revenue & Earnings Trend

In Q4 FY2026, ANSLY generated $1.12B in top-line revenue, marking a sequential increase of 8.6%. The company recorded net income of $120.2M, with diluted EPS of $3.36. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this mid-cap Healthcare company. Across the four most recent quarters, ANSLY averaged $2.15 in diluted EPS.

Company Profile

Ansell Limited operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Richmond, AU. The company is led by CEO Nathalie Ahlstrom. ANSLY has traded publicly since 2013.

Return on equity for Ansell Limited stands at 7.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.2%, showing how much profit it generates from its asset base. ANSLY trades at a trailing price-to-earnings ratio of 20.30, roughly in line with the Healthcare sector average of ~21.50x. Its free cash flow yield is 6.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.36 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 4.8%, the inverse of the P/E and a quick read on earnings relative to price.

Ansell Limited's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 4.11 places it in the safe zone, indicating low near-term bankruptcy risk.

Ansell Limited has beaten Wall Street's EPS estimate in 4 of its last 8 reported quarters — more hits than misses. Reported results have landed about 2.9% above estimates on average.

ANSLY Financials

ANSLY Latest News

ANSLY Analyst Consensus

ANSLY MoonshotScore

What Investors Ask About Ansell Limited (ANSLY) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources